These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26702072)

  • 1. Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome.
    Cramer NP; Xu X; F Haydar T; Galdzicki Z
    Physiol Rep; 2015 Dec; 3(12):. PubMed ID: 26702072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speeding of miniature excitatory post-synaptic currents in Ts65Dn cultured hippocampal neurons.
    Best TK; Cho-Clark M; Siarey RJ; Galdzicki Z
    Neurosci Lett; 2008 Jun; 438(3):356-61. PubMed ID: 18490108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Potassium and Cation Channels in Hippocampal Abnormalities of Embryonic Ts65Dn and Tc1 Trisomic Mice.
    Stern S; Segal M; Moses E
    EBioMedicine; 2015 Sep; 2(9):1048-62. PubMed ID: 26501103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.
    Contestabile A; Fila T; Ceccarelli C; Bonasoni P; Bonapace L; Santini D; Bartesaghi R; Ciani E
    Hippocampus; 2007; 17(8):665-78. PubMed ID: 17546680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome.
    Uguagliati B; Stagni F; Emili M; Giacomini A; Russo C; Guidi S; Bartesaghi R
    Dev Neurosci; 2022; 44(1):23-38. PubMed ID: 34852343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome.
    Mitra A; Blank M; Madison DV
    Brain Res; 2012 Feb; 1440():1-8. PubMed ID: 22284618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome.
    Lysenko LV; Kim J; Madamba F; Tyrtyshnaia AA; Ruparelia A; Kleschevnikov AM
    Neurobiol Dis; 2018 Jul; 115():1-8. PubMed ID: 29550538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal development of spinal neuronal and glial populations in the Ts65Dn mouse model of Down syndrome.
    Aziz NM; Klein JA; Brady MR; Olmos-Serrano JL; Gallo V; Haydar TF
    J Neurodev Disord; 2019 Dec; 11(1):35. PubMed ID: 31839007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of down syndrome carrying human chromosome 21.
    Shao LR; Gao F; Chinnasamy V; Kazuki Y; Oshimura M; Reeves RH; Stafstrom CE
    Neurobiol Dis; 2023 Aug; 184():106198. PubMed ID: 37315904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome.
    Thomazeau A; Lassalle O; Manzoni OJ
    Front Neurosci; 2023; 17():1171797. PubMed ID: 37841687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.
    Costa AC; Grybko MJ
    Neurosci Lett; 2005 Jul; 382(3):317-22. PubMed ID: 15925111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoproteomic Alterations of Ionotropic Glutamate Receptors in the Hippocampus of the Ts65Dn Mouse Model of Down Syndrome.
    Gómez de Salazar M; Grau C; Ciruela F; Altafaj X
    Front Mol Neurosci; 2018; 11():226. PubMed ID: 30140203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials.
    Scott-McKean JJ; Chang B; Hurd RE; Nusinowitz S; Schmidt C; Davisson MT; Costa AC
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3300-8. PubMed ID: 20130276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.